Ballantyne Therapeutics, Inc. announced it raised $400,000 in an initial filing from an offering of $500,000

Jul 14, 2015•about 10 years ago

Amount Raised

$400,000

Round Type

seed

North CarolinaHealthcare

Company Information

Company

Ballantyne Therapeutics, Inc.

Location

North Carolina, United States

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech